Agilent Technologies and SomaLogic will partner to expand the dissemination of Soma’s proteomic assay to at least five academic and contract research centers by the end of the year as demand for the tool has skyrocketed among biopharma companies.
Thermo Fisher Scientific has integrated Genedata's Expressionist software with its high resolution mass spectrometry (MS) offering to enable high-throughput metabolomics data processing.
Disease treatments could be developed faster thanks to a new
mathematical model that calculates how popular a protein is in
terms of how likely another protein will want to associate with it.
Ever since Bio-Rad's acquisition of Ciphergen's SELDI MS (surface
enhanced laser desorption/ionisation mass spectrometry) technology
late last year, it has been fighting against the spectre of
"controversial" research...
LabTechnologist.com brings you its periodic round up of industry
news with developments at Agilent, Biotage, Chenomx, Oxford Gene
Technology, Phenomenex and Sigma-Aldrich.
BG Medicine will integrate Applied Biosystems' state of the art
technology into its systems biology platforms to enhance its
biomarker discovery and monitoring programs.
Sigma-Aldrich launches the first commercially available proteomics
standard in which allows researchers to better assess proteomics
strategies, troubleshoot protocols and normalise results from day
to day and lab to lab.
Applied Biosystems has teamed up with Invitrogen to combine forces
on providing proteomic analyses and biomarker studies in drug
discovery and disease research.
Bruker Daltonics introduces a novel protein post translational
modification (PTM) discovery tool that represents the first
commercially available Electron Transfer Dissociation (ETD) module
for PTM discovery and de novo peptide sequencing...
Drug discovery company PerkinElmer and biotechnology company
Vivascience has announced the formation of a joint partnership and
distribution agreement in biomarker screening and discovery.
A report into the protein biochip industry identifies a major trend
emerging in protein production, either driven by gene approaches or
research purposes for therapeutic drug production. The report cites
growth in the US market to...
Ciphergen Biosystems has introduced its next generation ProteinChip
System, Series 4000, primarily designed to enable rapid biomarker
discovery and development of predictive, high throughput
SELDI-based assays.
Developer of life science tools Bruker Daltonics has introduced a
new research instrument for proteomics research at the laboratory
science exhibition Pittcon, taking place in the US this week.
